Bruck Claudine 4
4 · Annovis Bio, Inc. · Filed Jul 3, 2024
Insider Transaction Report
Form 4
Bruck Claudine
Director
Transactions
- Award
Stock Option (right to buy)
2023-11-17+26,200→ 26,200 totalExercise: $6.07Exp: 2033-11-17→ Common Stock (26,200 underlying)
Footnotes (2)
- [F1]On June 12, 2024, stockholders of Annovis Bio, Inc. approved an amendment to the 2019 Equity Incentive Plan to increase the number of shares issuable thereunder from 2,000,000 to 3,000,000. 50% of the stock option grant listed was contingent upon the approval of such amendment and would have been forfeited if the amendment had not been approved.
- [F2]The stock option shall vest immediately upon grant date.